Fig. 9

The low-risk group may be more sensitive to immunotherapies. a The differences in response results to immunotherapy between low-risk and high-risk groups. b The scatter plot shows the correlation between immunotherapy responsiveness and risk score in EC patients. c The relative probabilities of responding to anti-CTLA-4 antibody in the low-risk and high-risk groups. d The relative probabilities of responding to anti-PD-1/PD-L1 antibody in the low-risk and high-risk groups